Article: Alpharma Announces FDA Approval for Albuterol Inhalation Aerosol

FORT LEE, N.J., Aug. 26 /PRNewswire/ -- Alpharma Inc. (NYSE: ALO) today announced that its U.S. Pharmaceuticals Division (USPD) has received approval from the Food and Drug Administration to manufacture and market Albuterol Inhalation Aerosol, 90 mcg/Actuation.

Albuterol Inhalation Aerosol is the generic equivalent to Ventolin(R) Inhalation Aerosol from Allen and Hanburys, a division of Glaxo Inc., and is indicated for the prevention and relief of bronchospasm due to asthma and similar respiratory diseases.

Albuterol Inhalation Aerosol is Alpharma USPD's entry into a $500 million annual market. It represents another member of the respiratory ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!